December 12, 2024
September 17, 2024 - Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional). See NOFO PAR-24-297.
National Institute on Drug Abuse (NIDA)
The purpose of this notice is to inform applicants about a correction regarding the eligibility of foreign institutions in PAR-24-297 - Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional).
The notice of funding opportunity (NOFO) has been revised to clarify that foreign components, as defined in the NIH Grants Policy Statement, are allowed. As a result, Part 2. Section III. Eligibility Information has been updated as follows (changes are italicized and underlined):
1. Eligible Applicants
Foreign Organizations
The NOFO currently states:
Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
The NOFO has been modified to read (changes in underlined bold italics):
Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
All other aspects of this NOFO remain unchanged.
Please direct all inquiries to:
Hoang Le, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-451-8849
Email: [email protected]